Evaluate Bioequivalence of Voriconazole(200mg/Vial) .
Status:
Completed
Trial end date:
2020-06-21
Target enrollment:
Participant gender:
Summary
A Randomized, Single-dose, Two-way Crossover Study to Evaluate Bioequivalence of Two
Formulations of Voriconazole(200mg/Vial) After Intravenous Infusion of 200mg Voriconazole in
Healthy Volunteers Under Fasting Conditions.